Myriad Genetics (MYGN)
(Delayed Data from NSDQ)
$28.02 USD
+0.01 (0.04%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $28.03 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.01 | 0.00% |
Earnings Summary
For their last quarter, Myriad Genetics (MYGN) reported earnings of -$0.01 per share, beating the Zacks Consensus Estimate of $-0.11 per share. This reflects a positive earnings surprise of 90.91%. Look out for MYGN's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.01 per share, reflecting a year-over-year increase of 87.5%.
Earnings History
Price & Consensus
Zacks News for MYGN
Myriad Genetics (MYGN) Expands in MRD Testing With New Collab
MYGN: What are Zacks experts saying now?
Zacks Private Portfolio Services